FT-8225

N/A

Report date: 2023/02/18 19:35:22
NME

Base Information

Drug NameFT-8225
Drug Alias NameFT-8225
ClassificationSmall molecules
Mechanisms of ActionFatty acid synthase inhibitors
TargetsFatty acid synthase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesForma Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesForma Therapeutics Holdings Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A